Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma
Clinical trial NCT04288765 · WITHDRAWN
Trial details
- NCT number
- NCT04288765
- Sponsor
- Grupo Cooperativo de Hemopatías Malignas
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-01
- Primary completion
- 2024-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.